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ABSTRACT 
 
Background: The availability of information on profile and trends of cancer in South 
African populations is important for the development of appropriate cancer control 
strategies, as well as monitoring the efficacy of the existing cancer control programmes. 
Yet, generally there is a scarcity of systematically analysed reports on hospital cancer 
cases in South Africa, even for urban hospitals. The aim of this study was to describe the 
cancer profile of patients diagnosed at Frere Hospital‟s Oncology and Radiation 
Department and estimate the incidence of cancer among Buffalo City (BFC) urban area 
residents, for the 19-year period 01 January 1991 to 31 December 2009 based on the 
clinical administrative data system maintained by the department. 
 
Methodology: The study was a descriptive case series study based on a retrospective 
review of Frere Hospital‟s Oncology and Radiation Department patient records from 1991 
to 2009. Permission was obtained to retrieve records of cancer cases for the 19-year 
period from the database. Data were extracted from the customized administrative system 
to an excel spread sheet. Variables for each case retrieved included: socio-demographic 
details; age at diagnosis, sex, race, place of residence and medical aid information, tumor 
information; site and date of diagnosis. Data cleaning incorporated techniques such as 
checking of completeness and accuracy of patient information details. Dates were 
formatted into month-day-year sequence and checked so that the date of birth precedes the 
date of diagnosis of the patient and the date last seen. Age less than zero and greater than 
ninety nine was replaced as missing. Geographical areas were coded according to the 
South African Population Census. Duplicates and cases with missing diagnosis were 
excluded. 
  
STATA 12.0 analysis software was used to determine the proportion of cancer cases by 
age, sex and site. Frequency distribution tables and graphs were drawn and minimal 
cancer incidence rates were estimated based on population estimates from the 2007 
Community Survey and the 2011 Population Census. The rates were regarded as 
“minimal” and “working” estimates as the database reviewed was from only one of the 
two public hospitals in the study area and private hospitals‟ databases were not used. The 
other public hospital, Cecilia Makiwane, does not have an oncology department and 
private hospitals in the study area with radiology departments have issues of patient 
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information confidentiality. Age standardized rates were calculated using the World 
Standard Population generally applied to cancer incidence data. Poisson regression 
analysis model was used to assess trends in selected cancer rates over time adjusted for 
age and sex.  
 
Results: 19 737 (89.0%) of the 22 173 records retrieved were malignant cases. A total of 
7 656 (38.8%) were males and 12 081 (61.2%) were females. The average age at 
diagnosis for males was 56 years and for females 54 years. In males the top 5 cancers 
were lung (18.6%), larynx (8.3%), mouth (7.7%), prostate (7.1%), tongue (5.2%) whereas 
in females were cervix (36.6%), breast (22.0%), lung (3.5%), ovary (2.8%) and corpus 
uteri (2.7%). A total of 360 childhood (≤14 years) cancers was observed which accounted 
for 1.8% of all cancers. The leading childhood cancers were brain (20.8%), kidney 
(19.8%), eye (16.1%), Hodgkin‟s disease (7.8%) and lymphoid leukaemia (7.3%) in boys. 
Brain (21.4%), kidney (18.5%), eye (14.9%), bones, joints & articular cartilage (12.5%) 
and lymphoid leukaemia (10.1%) were leading cancers in girls. Estimates of cancer 
incidence rates for the BFC urban area sub-population showed that the overall age 
standardised rates (ASRs) for males were 83.2 per 100 000 population and for females 
83.3 per 100 000 population. Leading cancers in males were lung [22.5%, ASR 21.0 per 
100 000], prostate [14.7%, ASR 9.2 per 100 000], larynx [5.8%, ASR 5.0 per 100 000], 
mouth [4.4%, ASR 3.7 per 100 000] and colon [3.1%, ASR 2.9 per 100 000]. In females 
cervical [20.9%, ASR 23.0 per 100 000], breast [23.6%, ASR 20.2 per 100 000], lung 
[3.4%, ASR 4.7 per 100 000], ovary [2.1%, ASR 3.0 per 100 000] and corpus uteri [3.4%, 
ASR 2.8 per 100 000] were the leading cancers.  
 
Poisson regression analysis results showed an overall decreasing trend over the period in 
selected common cancers: lung, prostate and cervical with an exception of breast cancer 
trends which were observed as stable over the period. Compared to males, females were 
0.37 [95% CI: 0.05-0.40] less likely to have lung cancer. Analysis of race distribution of 
the cancers showed that lung, prostate and breast cancer incidence rate ratios were higher 
in the White population compared to the Black African population. White males were 
twice more likely to have lung cancer and almost five times more likely to have prostate 
cancer compared to Black African males.  White females were almost three times more 
likely to have breast cancer but 0.57 [95% CI: 0.12-0.66] less likely to have cervical 
cancer when compared to Black African females.  
 
 
 
 
 
 
x 
 
       
Conclusion: This study demonstrates that data retrieved at Frere Hospital‟s Oncology and 
Radiation Department were useful for describing the cancer characteristics of patients 
presented at this department, as well as in estimating the cancer incidence in an urban 
population of the Eastern Cape (EC) Province. However, the observed cancer pattern in 
BFC urban area was strikingly different from the profile which was previously reported 
for this area when oesophageal cancer was the leading cancer and lung cancer did not 
feature. Therefore, further studies to investigate oesophageal cancer cases that might not 
have been referred for radiotherapy in this hospital should be done. 
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CHAPTER I 
Introduction 
 
Cancer is emerging as a major public health problem in developing countries and strongly 
contributes to the observed epidemiological transition. The increase in cancer incidence is 
attributable to increasing population aging, as well as the adoption of lifestyle choices such as 
smoking, physical inactivity and westernized types of diet (Bello, Fadahun, Kielkowski & 
Nelson, 2011; Jemal, Bray, Center, Ferlay, Ward & Forman, 2011). Cancer incidence reports 
in South Africa are produced by the pathology-based National Cancer Registry (NCR) and 
the population-based Eastern Cape (EC) Province Cancer Registry, formerly known as the 
PROMEC Cancer Registry. The NCR was established in 1986 to provide information on 
cancer incidence nationally, based on histologically diagnosed cases in both public and 
private laboratories (Sitas & Isaäcson, 1992). The EC Province Cancer Registry was 
established in 1981 by the South African Medical Research Council to follow trends in the 
incidence of oesophageal cancer in two rural areas with high incidence and other two with 
low incidence (Somdyala, Marasas, Venter, Vismer, Gelderblom & Swanevelder, 2003). The 
registry has been expanded to cover all cancer sites that occur in the population living in 8 
magisterial areas of the former Transkei region of the EC Province (Somdyala, Bradshaw, 
Gelderblom & Parkin, 2010).  
 
According to the NCR, the annual number of new cancer cases reported by public and private 
pathology laboratories increased from 38 027 in 1987 to 45 570 in 1988 as well as from 60 
172 in 1998 to 60 343 in 1999 (Sitas & Isaäcson, 1992; Sitas, 1994; Mqoqi, Kellett, Sitas & 
Musa, 2004). However these were minimum numbers as pathology laboratories are located in 
cities and this means clinically diagnosed cases from the rural areas were excluded. NCR last 
reported cancer incidence rates in 2004 as a result of being held back by patient 
confidentiality issues and a lack of supportive legislation. The EC Province Cancer Registry 
reported cancer incidence in a rural population of the EC. The registry reported that the 
average annual number of new cancer cases increased from 500 cases per year for the period 
1998-2002 to 561 for 2003-2007 (Somdyala et al., 2010; Somdyala, Bradshaw & 
Gelderblom, 2013). It is therefore clear that cancer is not rare in South Africa. 
 
In recognition of the growing awareness of the burden of cancer in South Africa, important 
initiatives to prevent and control cancer have been implemented. These include the 
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amendment of the Tobacco Products Control Act as early as 1993 to restrict the advertising 
of tobacco products, prohibit smoking in public places and tobacco manufacturers‟ 
sponsorships, as well as raising the legal minimum age for purchasing tobacco from 16 to 18 
(Stefan, Elzawawy, Khaled, Ntaganda, Asiimwe, Addai, Wiafe & Adewole, 2013). This was 
a government effort to reduce lung cancer and other upper respiratory tract conditions 
associated with tobacco smoking.  The introduction of a cervical cancer screening 
programme in 2000 was proposed for screening women over the age of 30 years and offer 
asymptomatic women 3 free smears in a lifetime, 10 years apart (Denny, 2010).  However, 
the uptake and impact of this policy on cervical cancer incidence in South Africa has been 
poor due to its fragmented and unco-ordinated implementation (Denny, 2010; Stefan et al., 
2013).  
 
Additional cancer control initiatives include the establishment of a new regulation on cancer 
registration in April 2011 to enhance cancer reporting, revitalization of the NCR by the South 
African Department of Health and the establishment of a Ministerial Advisory Committee on 
the prevention and control of cancer in year 2012 (Stefan et al., 2013; South African 
Government, 2011). Cancer registration regulation makes it compulsory for every health 
facility to record and notify every cancer case that is diagnosed. However as imperative as it 
is to prevent and control cancer and henceforth strengthen cancer surveillance in health 
facilities, there remains the need to review previous cancer cases where routine patients‟ 
records are available so as to make the data informative.  
 
Problem Statement 
Frere Hospital is a large provincial government-funded hospital situated in East London, 
Eastern Cape Province in South Africa. It is a tertiary teaching hospital which was 
established in 1881 and forms part of the East London Hospital Complex with Cecilia 
Makiwane Hospital. The East London Hospital Complex departments include trauma and 
emergency department, orthopaedic surgery, paediatrics, obstetrics/gynecology, surgery, 
internal medicine, antiretriviral clinic for HIV/AIDS in adults and children, anaesthetics, 
family medicine, dermatology and burns unit. Of the two hospitals, Frere Hospital is the only 
hospital which has in addition to its departments an oncology department for adult and 
paediatric patients which offer oncology services such as medical, radiation and surgical care 
and an endoscopy theatre outpatient facility (EC Department of Health, 2012).  
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Endoscopy can be used for many procedures, but relevant to this study is its use in the 
investigation of symptoms in the digestive system and in the confirmation of a diagnosis, 
most commonly by performing a biopsy to check for cancers of the digestive system as well 
as in palliative care to widen narrow oesophogus. Patients visiting the oncology department at 
Frere Hospital are routinely recorded and their information is systematically maintained 
whereas those using the endoscopy facility in particular with oesophogus cancer are not 
systematically recorded. There is only one available systematically analysed report on cancer 
cases seen at Frere Hospital and this was prepared in 1957.  The report was based mainly on 
the work of clinicians who reported case series of patients with oesophageal cancer 
encountered during their professional lives (Burrell, 1957).  
Generally in South Africa descriptive epidemiology data on cancers are limited. There are no 
available data on cancer trends for the past 10 years as the South African NCR last reported 
data on a spectrum of cancers in 2004. In the EC Province specifically, detailed information 
on cancer cases that occur in rural populations is available through the EC Province Cancer 
Registry. However, information about cancers in urban population of the province is not 
available. Therefore, this study will be the first attempt in estimating cancer incidence in an 
urban population of the EC Province using clinical administrative data system which are 
generated and maintained by Frere Hospital‟s Oncology and Radiation Department. 
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CHAPTER II 
Literature review 
 
Hospitals and oncology units that routinely record and systematically keep patient 
information serve as good observation sites for cancer case monitoring (Jensen & Storm, 
1991; dos Santos Silva, 1999). Cancer incidence data generated from these sources are 
important as they inform research, health care planning, primary and secondary prevention 
and for planning/evaluation of programmes for cancer control. However, in some countries, 
particularly in Africa, routine recording of cancer patient information is sparse as cancer is 
under-emphasised due to the overwhelming burden of communicable diseases and this limits 
the availability of cancer incidence data (Parkin, Sitas, Chirenje, Stein, Abratt & Wabinga, 
2008). Therefore, regular estimates of cancer incidence in broad areas of the world have been 
made available by the International Agency for Research on Cancer (IARC) (Ferlay, Shin, 
Bray, Forman, Mathers & Parkin, 2010).  
 
Parkin, Pisani and Ferlay (1999) reported a total of 8.1 million new cancer cases in the world 
during the year 1990, with just over half occurring in developing countries. The authors 
estimated cancer incidence rates by age groups and sex for as many countries as possible and 
combined the estimates to produce weighted averages. They calculated age-standardised 
incidence rates using the weight of the “world standard” population. National incidence data 
for each country were preferred sources of data and the principal source was “Cancer 
Incidence in Five Continents; Volume VII” (CI5VII) (Parkin et al., 1999).  Lung cancer was 
reported as the most common cancer in the world, accounting for 18% of all cancers of men 
worldwide followed by cancer of the stomach which was almost 10% and breast cancer 
among women 21%. In developed countries these were followed by colo-rectal and prostate 
cancers whilst in developing countries cervical and oesophageal cancers (Parkin et al., 1999).  
 
Most recently, through the GLOBOCAN series which began in year 2002, the IARC 
published cancer incidence estimates at country level using national cancer data sources 
where possible with local data and statistical modelling where data are absent (Ferlay et al., 
2010). Ferlay et al., (2010) used GLOBOCAN 2008 to summarise global patterns for the 
eight most common cancers: lung, breast, colorectal, stomach, prostate, liver, cervical and 
oesophageal cancers. The authors rated oesophageal cancer as the eighth most common 
cancer in the world with 83% of the cases occurring in developing countries. Southern Africa 
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was observed to have the highest oesophageal cancer [ASR 22.3 in men compared to West 
Africa 14.1 and 11.7 in females compared to 0.6 in Micronesia per 100 000 population] and 
mortality rate in both sexes (Ferlay et al., 2010). In Uganda for the period 1991-2006, 
oesophageal [ASR 16.0 during 1991-1995, 12.5 during 1996-2001 and 15.4 during 2002-
2006 per 100 000] cancer formerly the most common cancer in men and second in frequency 
in women, is reported to have remained relatively constant, whereas the incidence of cancer 
of the cervix [ASR 38.1 during 1991-1995, 44.9 during 1996-2001 and 52.4 during 2002-
2006], the most common malignancy in women, continues to increase (Parkin, Nambooze,  
Wabwire-Mangen & Wabinga, 2010). The Malawi National Cancer Registry for the period 
1996-2005 reported oesophageal cancer [ASR 22.3 for males and 14.6 for females] as the 
third most common cancer after Kaposi sarcoma [ASR 50.5 per 100,000 for males, 26.4 for 
females] and cervical cancer [ASR 49.3 per 100 000] (Misiri, Dzamalala, Edriss, Parkin & 
Bray, 2012). According to the latest series GLOBOCAN 2012, an estimated 14.1 million new 
cancer cases occurred in 2012, compared to the 12.7 million in 2008 and the most diagnosed 
cancers were lung (13.0%), breast (11.9%) which had a sharp increase in incidence of more 
than 20% and colorectal [9.7%] (IARC, 2013).  
  
Cancer incidence in South Africa 
In South Africa attempts to describe the occurrence of cancer began as early as 1925, looking 
at the prevalence of cancer amongst the native races of the then Natal and Zululand during 
the period 1906-1909 (Pitchford, 1925). Later on, population-based cancer registries were 
established using standardised methods, first in Johannesburg and in the former Transkei 
region of the Eastern Cape, then in Cape Province and in Natal (Berman, 1935). In 1986, a 
national pathology-based cancer registry was established that covered the whole country.  
 
The Johannesburg Cancer Survey was conducted by the South African Institute for Medical 
Research and covered the metropolitan area of Johannesburg, consisting of the municipal 
area, and the peri-urban townships, notably Alexandra Township in the north-east and a 
cluster of townships in the south-west (Higginson & Oettle, 1966).  Liver [ASR 19.3 per 100 
000] and oesophageal cancers [ASR 12.4 per 100 000] were reported to be high for the period 
1953-1955 while lung was low [ASR 7.5 per 100 000]. In females, cervical [ASR 51.0 per 
100 000] and breast [ASR 14.9per 100 000] cancers were high, whilst oesophageal cancer 
was less than in males (ratio 10:1) (Higginson & Oettle, 1966). 
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The Cape Province cancer registry was a project of Cancer Research Unit of Groote Schuur 
Hospital in Observatory, and was mainly supported by the National Cancer Association of 
South Africa. The registry reported cancer cases for Black Africans, Coloureds and Whites 
for the period 1956-1958 (Muir Grieve, 1967). Even though the number of cases was less in 
Black Africans, oesophageal cancer [ASR 26.9 per 100 000] was reported more often 
followed by stomach [ASR 26.5 per 100 000] and liver [ASR 25.6 per 100 000] cancers. The 
Coloured population had high oesophageal [ASR 53.4 per 100 000] and lung [ASR 42.7 per 
100 000] cancers in men and high cervical [ASR 34.4 per 100 000], breast [ASR 25.8 per 100 
000] and oesophageal [ASR 25.5 per 100 000] cancers in women (Higginson & Oettle, 
1960). In the White population lung [ASR 44.8 per 100 000], stomach [ASR 32.9 per 100 
000] and prostate [ASR 24.2 per 100 000] cancers were reported as high in men whilst breast 
[ASR 57.6 per 100 000], stomach [ASR 22.9 per 100 000] and cervical [ASR 22.6 per 100 
000] cancers were high in women (Muir Grieve, 1967).  
 
The Natal Cancer Survey registered all new cancer cases of Black African and Indian 
populations for the period 1964-1966. Areas covered were the Metropolitan Area of Durban 
as well as the Magisterial District of Pietermaritzburg and case-finding for the Black Africans 
of Pietermaritzburg District was mainly based on pathology records (Schonland & Bradshaw, 
1968). In men, very high incidence of lung [ASR 43.4], oesophageal [ASR 40.1] and liver 
[ASR 27.6] cancers were reported whilst in females the cancer of the cervix was very high 
[ASR 48.5]. Oesophageal [ASR 12.0] and lung [ASR 10.1] cancers in females were about 
one quarter of those in men. In the Durban Indian group the overall incidence of cancer in 
males was low 7.3% compared to 13.8% in females and these were found by analysis of 
death certificates only. The incidence of gastro-intestinal tract (oral cavity and pharynx, 
oesophagus, stomach, colon, rectum) cancers was higher in Indian females than in males. In 
males, only stomach cancer [ASR 20.9 per 100 000] was high, while in females the highest 
incidence rates were for cervix uteri [ASR 34.7 per 100 000], stomach [ASR 29.1 per 100 
000], breast [ASR 19.4 per 100 000], oesophageal [ASR 12.7 per 100 000] and corpus uteri 
[ASR 12.8 per 100 000] (Schonland & Bradshaw, 1968). 
 
The South African National Cancer Registry (NCR) was established at the South African 
Institute for Medical Research; now the National Health Laboratory Service (NHLS) as a 
collaborative venture with the Cancer Association of South Africa (CANSA) and the 
Department of Health (DoH) (Berman, 1935). The registry provided national cancer 
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incidence rates based on the information of cancer cases diagnosed in both private and public 
laboratories. NCR results were published in series of publications (Sitas, Terblanche & 
Madhoo, 1996; Sitas, Blaauw, Terblanche, Madhoo & Carrara, 1997; Sitas, Madhoo & 
Wessie, 1998; Mqoqi et al., 2004). In males prostate [ASR 37.6 & 34.1 per 100 000], lung 
[ASR 15.2 & 13.6 per 100 000] and oesophageal [ASR 12.6 & 11.3 per 100 000] cancers 
were reported as the leading cancers for the years 1998 and 1999 respectively. In females, 
cervical [ASR 34.4 per 100 000] was the leading cancer in 1998 followed by breast [ASR 
32.7 per 100 000] and colorectal cancer [ASR 5.8 per 100 000]. In 1999 breast cancer [ASR 
33.4 per 100 000] was the highest, followed by cervical [ASR 28.7 per 100 000] and colo-
rectal cancer [ASR 6.6 per 100 000] (Mqoqi et al., 2004).  
 
Cancer incidence in the Eastern Cape Province 
In the Eastern Cape Province, an apparent increase in oesophageal cancer was observed in 
Black African patients at Frere Hospital in East London in 1956 and this initiated an 
investigation into the cause of the disease (Burrell, 1957). Burrell (1957) reviewed Frere 
Hospital‟s in-patient register for the period 1952-1956 and found that oesophageal cancer was 
diagnosed in approximately one of every 3, 500 general Black patients in the hospital. This 
incidence rate was believed as one of the highest ever recorded (Burrell, 1957). Furthermore, 
Burrell‟s report showed that top cancer sites during the period were cervix (20.6%), 
oesophagus (14.7%), tongue (10.0%), breast (8.9%) and mouth (6.9%), highlighting that a 
large number of patients with oesophageal cancer were males. In relation to which third of 
the oesophagus was affected, 70% of Black urban males predominantly had lesions in the 
middle of the oesophagus.  
 
Follow up enquiries into the bona fides of oesophageal cancer patients at Frere Hospital 
showed that an unexpected large number of the patients were from the Transkei region 
(Burrell, 1957). Subsequently, records of nearby hospitals together with those of hospitals in 
Transkei were checked and they also showed a similar situation (Rose, 1965; Rose, 1973). 
During this period a cancer register was established in East London in which information on 
oesophageal cancer and other cancers was collected with the enthusiastic reporting from 
doctors of the former Transkei (Rose, 1973). Even though the registry was in East London, 
the former Transkei was the main focus of cancer registration and studies.  
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In order to describe the geographical variation and temporal trends in the incidence of 
oesophageal cancer, Burrell and Rose made further investigations (Rose, 1975). In a 
preliminary survey for the period 1955-1959 in twenty six districts of Transkei, Burrell 
(1962) observed that oesophageal cancer incidence was high particularly in Butterworth and 
Centane; the south-western districts of the former Transkei and was the most common form 
of cancer in males and second to cervical cancer in females. Thereafter, Rose (1973) did a 15-
year survey (1955-1969) and particularly increased checks for cases in the north-eastern 
hospitals. In this survey, Rose reported that the incidence rates in south-western districts were 
much higher than the rates in north-eastern districts.  
 
Due to marked variation in the reported incidence of oesophageal cancer, data quality was 
improved by instituting field services on a house-to-house visiting basis (Rose & McGlashan, 
1975). Rose and McGlashan (1975) presented data on the incidence of cancer of the 
oesophagus for the period 1965-1969, discussed age-specific rates for the sexes and further 
demonstrated the special relationship of well-defined regions of high and low incidence. 
Elsewhere in South Africa, Transvaal and Natal, increased oesophageal cancer incidence was 
continuously reported in urban hospitals (Higginson & Oettle, 1960). Rose (1973) believed 
that the increase in urban incidence in Transvaal was due to the increase in migration from 
the former homelands of Transkei and Ciskei to Transvaal and this was supported by several 
reports on the patterns of cancer in African gold miners (Berman, 1935; Harington, 
McGlashan, Bradshaw, Geddes & Purves, 1973; Robertson, Harington & Bradshaw, 1971a).  
 
The South African Medical Research Council restructured the registry since 1986 and all 
cancer sites were included (Jaskiewicz, Marasas & Van de Walt, 1987). The population 
included residents in Butterworth and Centane; the so-called hot spots of oesophageal cancer 
which are in south-western area and Bizana and Lusikisiki, the so-called low incidence areas. 
An active method was used in case finding and hospitals in the registration area were visited 
where information on new cancer cases was obtained from hospital records. The results 
showed oesophageal cancer as the leading cancer, accounting for 41.3% of all reported 
cancer cases with an overall ASR of 28.4 per 100 000 and 17.8 per 100 000 males and 
females respectively (Jaskiewicz et al., 1987).  The comparison of  rates in the four districts 
during the periods 1955-1959, 1965-19695 and 1981-1984 revealed progressive increases 
among both sexes in both the north-eastern districts; and decreases among both sexes (but 
particularly among males) in the south-western district of Butterworth. Rates in Centane 
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remained high, with increasing trends in both sexes during 1981-1984. During the period 
1965-1984 the population increase was similar (approximately 30%) in the three rural 
districts of Bizana, Lusikisiki and Centane, whereas the population of the industrialised 
Butterworth district doubled during the same period (Jaskiewicz et al., 1987; Makaula, 
Marasas, Venter, Badenhost, Bradshaw, Swanevelder, 1996).  
 
The changes on incidence trends of oesophageal cancer and other cancers in the four districts 
of Transkei were further reported by Somdyala et al., (2003). Somdyala et al., 2003 reported 
oesophageal cancer as the most frequently reported cancer in both males and females with 
high incidence rates in Centane. For males oesophageal cancer was the lowest in Bizana 
whilst for females it was the lowest in Butterworth. Liver cancer was reported as the second 
most common cancer in males whilst cervix and breast cancers were the second and third 
most common cancers in females (Somdyala et al., 2003).  High incidence rates of cervical 
cancer in Lusikisiki were reported. These rates were reported to be comparable to the rates 
reported by the NCR, based on information collected from pathology laboratory records, 
from 1990-1995 (Somdyala et al., 2003; Sitas et al.,1996; Sitas et al.,1997; Sitas et al., 
1998). 
 
Population-based cancer registration in the Eastern Cape Province became stable in 1998. 
The following eight magisterial areas were covered; Butterworth, Centane, Idutywa, 
Nqamakwe, and Willowvale in the South West; Bizana, Flagstaff, Lusikisiki in the North 
East) of the former Transkei region (Somdyala et al., 2010). Sources of data included 15 
hospitals; 8 district hospitals, 6 referral hospitals and a pathology laboratory under the NHLS. 
Somdyala et al., (2010) reported overall cancer age standardised incidence for this rural 
population as 72.4 for males and 63.7 for females with oesophageal cancer during this period 
still the most frequently reported cancer in males and second-most common cancer in 
females. Other common cancers in males were lung, prostate and liver cancers. Cervical and 
breast cancer were the most frequently reported cancers in females in this population 
(Somdyala et al., 2010). Mqoqi et al., (2004) reported oesophageal and cervical cancer as 
common among Black South African females, with prostate and lung cancers remaining high 
in South African males.  
 
In conclusion, a number of attempts have been made to estimate the burden of cancer in 
South Africa. The methodologies used in these various attempts have differed but produced a 
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picture of the cancer status in different parts of the country. Various reports showed that 
South Africa, especially the former Transkei region of the Eastern Cape Province 
experienced a high incidence of oesophageal cancer. So far cancer registration done in the 
former Transkei still remains the only work established in a rural population in the Eastern  
Cape Province and in South Africa and has managed to contribute comparative information 
that can assist in tracking the diversity of cancer patterns (Somdyala et al., 2010).  It is 
therefore worthwhile to determine the present profile of cancer in an urban hospital of the 
Eastern Cape Province and provide working estimates of the incidence of cancer in an urban 
population of the province.  
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CHAPTER III 
Methodology 
 
Aim 
The aim of the study was to describe the profile of cancer cases presented at Frere Hospital‟s 
Oncology and Radiation Department and to estimate cancer incidence rates of Buffalo City 
(BFC) urban area residents for the period 1991-2009. 
 
Objectives 
1. To determine the number of cancer cases seen at Frere Hospital‟s Oncology 
and Radiation Department and the proportion by cancer site 
2. To describe the population characteristics (age, sex, race, geographic profile) 
of individuals who presented at this Oncology and Radiation Department with 
cancers   
3. To estimate minimal cancer incidence rates of BFC residents by age, sex and 
cancer site 
4. To determine cancer trends in patients treated at this department in terms of 
cancer site from January 1991 to December 2009 
 
Study Design 
This a descriptive case-series study. This method was used to describe the pattern of cancer 
occurrence in relation to variables such as person, place and time (Grimes & Schultz, 2002).  
This was an initial enquiry into what is the burden of cancer at Frere Hospital and the profile 
of cancers in an urban population of BFC urban area (Beaglehole, Bonita & Kjellstrom, 
1997). It was anticipated that results from this kind of study would provide knowledge about 
which racial groups are most or least affected by the disease and generate a hypothesis to 
identify descriptive characteristics of patients with cancer at this hospital. This constitutes an 
important first step in search for determinants or risk factors and trends analysis (Grimes & 
Schultz, 2002). Sampling was based on the presence of a specific outcome which was cancer 
(Dekkers, Egger, Altman & Vandenbroucke, 2012).  
 
Study population 
EC Province is the second largest province in South Africa and has the third largest 
population, approximately 6.5 million people, which is 12.7% of South Africa‟s population 
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(Statistics South Africa, 2012). The demographic profile of the residents indicates that the 
population aged 14 years or below decreased from 36.6% in 2001 to 33.0% in 2011 whilst 
between ages 15 and 64 years increased from 57.1% to 60.2% (Figure 1). The proportion of 
females in the province is 52.9% whilst males are 47.1%. Black Africans constitute the 
largest group of the population at 86.3%, followed by Coloureds (8.3%), Whites (4.7%), 
Asians (0.4%) and the remaining 0.3% are other. Trends in the unemployment rate indicate a 
decrease from 54.3% in 2001 to 37.5% in 2011. Proportions of households with electricity 
and piped water increased significantly across all the districts of the province from 2001 to 
2011(Statistics South Africa, 2012). 
 
There are two major urban areas within the EC Province, namely Nelson Mandela 
Metropolitan and Buffalo City (BFC). BFC is the key urban area of the eastern part of the 
EC. It consists of several urban areas, stretching from the port city of East London to the east, 
through to Mdantsane and reaching Dimbaza in the west. According to census 2011 the size 
of BFC population is 755 198 (Statistics South Africa, 2012). Frere Hospital, situated in East 
London, forms part of the East London Hospital Complex which offers specialist medical 
care to the largest population in the province. This hospital is a major referral hospital for 
patients from Amathole, Chris Hani, OR Tambo, Ukhahlamba and Alfred Nzo Health 
Districts. The study population was all cancer patients who visited Frere Hospital Oncology 
and Radiation Department.  
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Figure 1. Eastern Cape Province population distribution by age and sex (Statistics 
South Africa, 2012) 
 
Sampling 
Two sampling strategies were adopted. The first sampling strategy was for examining the 
burden of cancer in the hospital and covered objectives 1 to 2. It was an inclusive time-
delimited sampling of all patients presenting with malignant cancers who visited the 
Oncology and Radiation Department between 01 January 1991 and 31 December 2009. This 
was the most recent period for which data were available and appeared up-to-date. The 
second sampling strategy was a sub-sample to estimate the minimal cancer incidence rates for 
a population of a defined geographical area and covered objectives 3 and 4. Since this was a 
19-year review, case recurrences and metastasis in the same individuals were excluded.  A 
commonly regarded conclusion was that most cancer cases would have been attended to at 
this hospital as it is the only public hospital with an oncology specialist and provides 
oncology services in the region.  
 
Data collection 
Frere Hospital‟s Oncology and Radiation Department‟s database dates back to the year 1990. 
The database is generated by continuously recording of each patient visiting the facility on a 
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daily basis. Recording into a Radiotherapy (RT) programme is done by the departmental data 
clerks using pre-defined variables. The database was reviewed retrospectively for a period of 
19 years, from 01 January 1991 to 31 December 2009. An Information Technology (IT) 
specialist assisted with extracting data from the department‟s database software and transfer 
them into an excel spread sheet in order to prevent alterations to the database. IT specialist 
was necessary for his specialty in transferring data from a non-user friendly to user-friendly 
software (which was Excel in this study). Key variables that were extracted included patient 
demographics (including first name, surname, sex, age, address and racial group), tumor 
information; site and date of diagnosis.  
 
Data analysis 
Data cleaning 
Data cleaning incorporated techniques such as checking of completeness and accuracy of 
patient information details. Mandatory variables such as demographic information, diagnosis 
and the date of diagnosis were checked if they were available and complete for each patient. 
Clerks at Frere Hospital‟s Oncology and Radiation Department were contacted to verify and 
correct identified errors. The accuracy of information was checked by performing validation 
and consistency checks. Validation checks were carried out on International Classification of 
Diseases (ICD-10) codes. Codes which were in ICD-9 format were converted into ICD-10. 
Consistency checks were carried out to ensure the concordance of specified data items 
against other recorded items e.g. prostate cancer in a female or cervical cancer in male.  
 
Dates were formatted into month-day-year and sequence checked so that the date of birth 
precede the date of diagnosis of the patient and the date last seen. Age less than zero and 
greater than ninety nine was replaced as missing. Geographical areas were coded according to 
the South African Population Census. Data were further cleaned for inclusion in the analysis. 
Cases which were excluded from the analysis included duplicate cases, non-malignant cases, 
as well as cases with missing diagnosis and age. 
 
Analysis 
Data were subsequently analysed using STATA 12.0 analysis software to determine the 
proportion of cancer cases by age, sex and site. The number of cancers diagnosed are 
presented by year, sex, race, area together with top 10 cancer types from 1991-2009. Minimal 
cancer incidence rates for the BFC sub-population were estimated using population estimates 
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from the 2007 Community Survey and the 2011 population census. The direct method of 
standardization was used. ASRs were calculated by applying the age-specific rates in the 
BFC population to the fixed reference population which is the World Standard Population 
generally applied to cancer incidence data (Parkin, Whelan, Ferlay, Raymond, & Young, 
1997). Poisson regression model was used to assess trends in cancer rates for 2 most common 
cancers in males and females over time adjusted for age and sex and interactions between 
time and race. Establishing the uninsured population of the study was considered but was not 
possible according to the available information in the database. This would have provided a 
better denominator especially for interpreting the cancer trends by race. 
 
 
Validity and reliability 
The validity of this study depended on how accurately data clerks recorded the information. 
All the cases in the oncology department‟s database were assumed to follow the same pattern, 
that of pre-defined variables. In this study validity of cases in the database was verified by 
checking the number of cases with all pre-defined variables. The study was accepted to be 
valid as 92.5% of the cases had all the pre-defined variables.  
 
Reliability is the repeatability of study methods. In this study it was achieved by randomly 
selecting 50 cases which were collected from patient folders in Frere Hospital Oncology and 
Radiation Department by the Eastern Cape Province Population-Based Cancer Registry for 
the period 1998 to 2002 using cancer notification forms (Appendix A). A comparison of 
these cases together with the cases in Frere Hospital Oncology and Radiation Department 
database was done to check the accuracy of the information in both sets. In addition, a 
standard protocol was defined before commencement of the study - it was applied 
consistently.    
 
Ethical considerations 
General ethical principles when dealing with patient information include the respect of 
patient information and maintenance of confidentiality. Ethical approval was obtained from 
the University of the Western Cape Ethics Committee before commencement of the study 
(ethics reference number: 13/2/26 [Appendix B]). Furthermore, permission was obtained 
from the Director of Clinical Governance of Frere Hospital and the Research Committee of 
the Eastern Cape to access patient records and perform the study (Appendix C). Careful 
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measures on confidentiality regarding patient information were exercised. Data were stored in 
a computer database which was password-protected, accessible only to the principal 
researcher. Anonymity was also exercised during reporting as no patient names or identifiers 
were included. Vulnerability of the study population was not an issue and no harm was done 
during the performance of the study.  
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CHAPTER IV 
Results 
 
Records retrieved 
Eighty nine percent (n = 20 350) of the 22 173 records retrieved were malignant cases and 
had all the variables for analysis as shown in Figure 2. The trend in the annual number of 
records retrieved for the period 1991 to 2009 is shown in Figure 3. Records of non-malignant 
case 8.2% (n = 1 823) were for patients who visited the department for further investigations 
on non-neoplasm disorders, events of undetermined intent, complications of medical and 
surgical care, treatment of neoplasm of unknown behaviour of endocrine glands and 
thyrotoxicosis as defined by the ICD-10 codes in the records. The remaining 2.8% (n = 613) 
of cases were excluded because the respective ages of the patients had not been recorded.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Data exclusion steps 
 
22 173 records retrieved from database 
20 350 records of cases were malignant  
 
19 737 records of cases were malignant 
and had all variables for analysis  
 
1 823 records of cases were non-malignant   
613 records of cases were missing age   
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Figure 3. Annual number of records retrieved from Frere Hospital, 1991-2009 
 
Characteristics of cancer patients 
The annual number of malignant cases was consistent for the 19-year period with a slight rise 
in number of cases observed in years 2007 and 2009 (Figure 4). A total of 7 656 (38.8%) 
were males and 12 081 were females (61.2%). The distribution of the cases by sex is shown 
in Figure 5. The frequency of both male and female patients remained stable for the first half 
of the study period, then increased in the last half for the females whilst that of males 
decreased. The mean age at diagnosis for males was 56 (+/- 17.0) years and for females 54 
(+/- 16.5) years. Figure 6 shows that the majority of patients were Black Africans (81.5%), 
followed by Whites (13.5%), Coloureds (4.5%) and Asians (0.5%). The geographical 
distribution of patients within the EC is shown in Table 1. A proportion of 45.9% of the 
patients was from BFC district. Other patients were from the rest of Amathole (17.8%), OR 
Tambo (14.4), Chris Hani (14.2%), UKhahlamba (3.7%), Alfred Nzo (2.0%), Cacadu (0.5%) 
and Nelson Mandela (0.4%) Health Districts whilst 1.1% were from areas outside the Eastern 
Cape Province (Table 1). Figure 6 also shows that the total number of cancer patients with 
available medical aid information dropped to zero by year 2009.  
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Figure 4. Annual number of malignant cases from Frere Hospital, 1991-2009 
 
 
Figure 5. Proportion distribution of malignancy cases by sex, Frere Hospital 1991-2009 
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Figure 6. Proportion distribution of malignant cases by race, Frere Hospital 1991-2009 
 
 
 
Table 1. Geographical distribution of malignant cases in the EC Province Districts, Frere 
Hospital 1991-2009 
EC Health Districts  Number of cases % of cases 
Buffalo City 10 176 45.90 
Amathole 3 954 17.83 
OR Tambo 3 195 14.41 
Chris Hani 3 140 14.20  
UKhahlamba 828 3.73 
Alfred Nzo 436 1.97 
Cacadu 110 0.50 
Nelson Mandela 97 0.44 
Outside EC  237 1.07 
Total 22 173 100 
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Figure 7. Annual number of patients with medical aid and those without, Frere Hospital 
1991-2009 
 
Appendix D shows the total number and the percentage frequency of malignant cases by 
cancer site, age and sex from 01 January 1991 to 31 December 2009. The majority of cancer 
sites were concentrated within the older age groups in both males and females with fewer 
cases in younger age groups. A high number of unknown primary site cases (2.9% in males 
and 1.2% in females) and ill-defined cases (2.0% in males and 1.2% in females) was 
observed in both males and females. Figure 9 shows the ranking of the leading 10 cancer sites 
by sex and compared the percentages between males and females. Leading cancer sites which 
were common in both sexes were greater in males compared to females. In males the top-5 
common cancers were lung (18.6%), larynx (8.3%), mouth (7.7%), prostate (7.1%), tongue 
(5.2%) whereas in females were cervix (36.6%), breast (22.0%), lung (3.5%), ovary (2.8%) 
and corpus uteri (2.7%). A total of 360 childhood (children less than 14 years) cancers was 
observed during this period (Figure 10) and these accounted for 1.8% of all cancers recorded 
for the period 1991-2009. The top-3 cancers were that of the brain (21.1%), kidney (19.2%) 
and eye (15.6%). 
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Figure 8. Overall top-10 cancer sites from Frere Hospital, 1991-2009 
 
 
Figure 9. Top-10 cancer sites by sex from Frere Hospital, 1991-2009 
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Figure 10. Top-10 leading childhood (0-14 years) cancers for boys and girls, Frere 
Hospital    1991-2009 
 
Age standardised incidence rates 
The estimated age specific cancer incidence rates by site, age group and sex together with the 
percentage frequency, crude rates and ASRs for BFC sub-population, 1991-2009. The overall 
ASRs for males was 83.2 per 100 000 population and for females it was 83.3 per 100 000 
population as shown in Appendix E. Age distribution of cancer incidence rates is shown in 
Figure 11 with rates peaking from middle age and more females compared to males were 
observed . Figure 12 shows the ranking of the top-10 canncer sites by sex. In males the top-5 
cancer sites were lung [22.5%, ASR 21.0 per 100 000], prostate [14.7%, ASR 9.2 per 100 
000], larynx [5.8%, ASR 5.0 per  100 000], mouth [4.4%, ASR 3.7 per 100 000] and colon 
[3.1%, ASR 2.9 per 100 000] whilst in females were cervix [20.9%, ASR 23.0 per 100 000], 
breast [23.6%, ASR 20.2 per 100 000], lung [3.4%, ASR 4.7 per 100 000], ovary [2.1%, ASR 
3.0 per 100 000] and corpus uteri [3.4%, ASR 2.8 per 100 000].  
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Figure 11. Age Standardised Incidence Rates per 100 000 population by sex, Frere 
Hospital 1991-2009 
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Figure 12. Leading cancer incidence rates by sex, Frere Hospital 1991-2009 
 
Cancer trends and differentials, BFC 1991-2009 
ASRs of leading cancers in males and females are shown for each year for the 19-year period 
in Figure 13. When looking at the two leading cancers in males, prostate cancer decreased 
considerably from year 1999 onwards while lung cancer decreased between 2000 and 2003 as 
well as from 2006 onwards. In females cervical and breast cancer incidence rates remained 
stable over the period.  
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Figure 13. Age standardised rates trends of the leading cancers in males and females, 
Frere Hospital 1991-2009   
 
Poisson regression analysis was applied to the incidence rates to assess the trends over time 
adjusted for age. Females were 0.63 less likely to have lung cancer compared to males. The 
comparison of incidence rates showed that White males were two times more likely to have 
lung cancer and five times most likely to have prostate cancer than Black African males. 
White females, on the other hand, were three times more likely to have breast cancer and 
were 0.43 less likely to have cervical cancer compared to Black African females. Incidence 
rate ratios are shown for four 5-year periods in Figure 14 and 15. Although the rates tended to 
decrease over this period, there were no significant changes over time in the leading cancers.  
 
Figures 16 and 17 show age-specific incidence rate ratios with a 95% confidence interval (CI) 
for the selected cancers in males and females, all cancers were observed to be increasing with 
age. Race distribution of the selected cancers is shown in Figures 18 and 19. Lung, prostate 
and breast cancer incidence rate ratios were higher in the White population compared to the 
Black African population. White males were twice more likely to have lung cancer and 
almost five times likely to have prostate cancer compared to Black African males.  White 
females were almost three times more likely to have breast cancer but 43% (95% CI: 0.12-
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0.66) less likely to have cervical cancer when compared to Black African females.  
  
Figure 14. Trends in incidence rate ratios of selected cancer sites in males, Frere 
Hospital 1991-2009 
 
 
 
Figure 15. Trends in incidence rate ratios of selected cancer sites in females, Frere 
Hospital 1991-2009 
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Figure 16. Age-specific incidence rate ratios of selected cancers in males, Frere Hospital 
1991-2009 
 
 
 
Figure 17. Age-specific incidence rate ratios of selected cancers in females, Frere 
Hospital 1991-2009 
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Figure 18. Lung cancer incidence rate ratios by sex, Frere Hospital 1991-2009 
 
 
Figure 19. Male selected cancer incidence rate ratios by race , Frere Hospital 1991-2009 
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Figure 20. Female selected cancer incidence rate ratios by race, Frere Hospital 1991-
2009 
 
 
Breast and prostate cancers rate ratios observed in White population were higher than in 
Black Africans even though the annual race-distribution observed in Figure 6 showed that the 
White population decreased over the 19 year period. Poisson regression was used to further 
investigate the interaction between period and race for the subset of Black African and White 
patients. The analyses showed that the trend in the rates for the Whites contributed 
significantly to the overall decrease in all the three cancer site incidence rates over the period, 
whilst Black African male rates did not decrease for prostate cancer and Black African rates 
for female breast cancer increased over the same period (Figures 21-23).  
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Figure 21. Lung cancer year and race interaction, Frere Hospital 1991-2009 
 
 
 
Figure 22. Prostate cancer year and race interaction, Frere Hospital 1991-2009  
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Figure 23. Breast cancer year and race interaction, Frere Hospital 1991-2009 
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CHAPTER V 
Discussion 
 
The annual number of malignant cases at Frere Hospital increased from 953 in 1991 to 1 414 
in 2009. More than half of the malignant cases were observed in females (61.2%). Most 
importantly this pattern reflects the greater cancer burden in women from reproductive causes 
observed in this study with cervical and breast cancers being the two leading cancers in 
females. According to GLOBOCAN 2012 cancer trends world wide in developing countries 
going through rapid and economic changes,  show that the shift towards lifestyles typical of 
industrialised countries lead to a rising burden of cancers associated with reproductive factors 
(IARC, 2013, McCormack & Schuz, 2011). The greater proportion of female cancer cases 
observed in this study could also be due to the well-known hypothesis that females are more 
likely to seek health care or are more compliant to therapeutic regimen compared to males 
(Norcross, Ramirez & Palinkas, 1996; Muriithi, 2013). However, this needs to be interpreted 
with care as this hypothesis was not explored in this study.  
 
Black African population patients formed the majority of patients with cancer and showed an 
overall increase from 1991 to 2009 whereas the White  population decreased. The high 
number of Black African patients was expected as Black Africans form the majority of the 
Eastern Cape Province population. The annual number of patients with medical aid 
information decreased from 144 in 1999 to zero in 2009. The medical aid information 
available in the data was thought to be unreliable even though it probably indicated a trend 
with fewer private sector patients at Frere Hospital. The majority of cancers were adult 
cancers, with a few childhood ones. Even though the study presented cancers by sites, 
unknown primary and ill-defined cancer site cases were included in the analysis and both had 
considerably high numbers in both males and females.  
 
This study showed that the top-10 leading cancers treated at Frere Hospital‟s Oncology and 
Radiation Department for the period 1991-2009 in males were lung, larynx, mouth, prostate, 
tongue, oesophageal, colon, pharynx, tonsil and Non-Hodgkin‟s lymphoma. In females 
cervical, breast, lung, ovary, corpus uteri, mouth, colon, Non-Hodgkin‟s lymphoma, 
oesophageal and Kaposi sarcoma were the top-10 cancers. Common childhood cancers in 
both boys and girls were brain, kidney, eye, bone, lymphoid leukaemia, Hodgkin‟s diseases, 
Non-Hodgkin‟s lymphoma, connective and soft tissue, testis and ovary cancer. The top-10 
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leading cancers for the BFC population males changed and were lung, prostate, larynx, 
mouth, colon, tongue, oesophageal, rectum, Non-Hodgkin‟s lymphoma and multiple 
myeloma, whereas in females they remained the same as overall cancers.  
 
A comparison of the overall leading cancers observed in this study for the period 1991-2009 
with those observed for the period 1952 to 1956 by Burrel is shown in Figure 24. The 
observed cancer pattern in BFC is strikingly different from the profile reported for this area 
by Burrell in 1957 when oesophageal cancer was the leading cancer and lung cancer did not 
feature. The absence of oesophageal cancer in the top three cancers in this data is also 
striking when compared with contemporary data reported by the rural population-based 
cancer registry in the former Transkei region of the Eastern Cape (Somdyala et al., 2013). 
Oesphageal cancer has been the leading cancer in the rural area with high rates observed for 
both males and females (Figure 25). It is possible that the clinical administrative data used in 
this study is missing oesophageal cancer cases that might not have been referred for 
radiotherapy in this hospital.  
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Figure 24.  A comparison of leading cancer sites for the periods (a)1952-1956 and (b) 
1991-2009  
 
 
 
 
 
 
 
 
 
36 
 
In this study lung cancer was the most common cancer in males accounting for 18.6% of all 
cancers whilst in females it was 3.5%. Tobacco smoking is reported to be one of the most 
important risk factors for lung cancer (Sitas, Parkin, Chirenje, Stein, Abratt & Wabinga, 
2008; Mqoqi et al., 2004; Bello et al., 2011). This observed high pattern of lung cancer in 
males in this study is related to the deaths due to cigarette smoking in South Africa which 
were reported to be 61% in males and 48% in females (Sitas, Urban, Bradshaw, Kielkowski, 
Bah & Peto, 2004). This high lung cancer pattern was expected as the relative risk of 
tobacco-related cancers in males in urban areas of South Africa is reported to be 21 compared 
to rural smoking males, which is 13 (Sitas et al., 2008).  
 
Trends in lung cancer over the period were observed to have decreased and this was 
comparable to the national decrease in prevalance of smoking amongst adults as well as in 
learners (from 23% in 1999 to 16.9% in 2011) reported in South Africa (Reddy, James, 
Sewpaul, Yach, Resnicow, Sifunda, Mthembu & Mbewu, 2013; Mayosi et al., 2009).  The 
decline in reported smoking prevalance rates together with the incidence rates in this study 
could be expected as South Africa is reported to have been a leader in the development and 
implementation of an appropriate tobacco control plan (Mayosi et al., 2009). Other smoking-
related cancers observed to be high in males in this study were mouth [ASR 3.7 per 100 000 
population] and tongue [ASR 2.9 per 100 000 population] cancers.  
 
Prostate cancer was one of the leading cancers in males in this study, accounting for 7.1% of 
all male cancers. This cancer which was reported as one of the less frequent cancers (1.7%) in 
males by Burell (1957) ranked as the second-most common cancer for the BFC population 
with an ASR of  9.2 per 100 000 population. South Africa is reported to have the highest 
incidence of prostate cancer [40.5 per 100 000] compared to other African countries. The 
incidence of histologically-verified prostate cancers is reported to be higher in the White 
population [40.5 per 100 000 population] compared to the Black African population [14 per 
100 000 population] (Parkin et al., 2008). In this study prostate caner incidence rates were 
almost five times higher in the White population compared to the Black African population. 
An overall decrease in trends of prostate cancer over the 19-year period was observed. The 
interaction between race and time showed that this trend was due mostly to the decrease in 
number of the White male population cases whilst Black African male cases were stable. This 
could be attributable to White males moving to private practices as Frere Hospital is a public 
hospital.       
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In this study female reproductive system cancers (cervix and breast) were the leading in 
females. These are also reported to be the most common cancers in females in Africa as a 
whole. The incidence of cervical cancer [30-40 per 100 000] is reported to be highest in 
eastern and southern Africa whilst that of breast cancer [35 per 100 000] is the highest in 
South Africa  (Parkin et al., 2008; Denny, 2010). The South African NCR reported cervical 
cancer ASR of 34.3 per 100 000 and 28.7 per 100 000 for the year 1998 and 1999 
respectively. Over 80% of the women diagnosed with cervical cancer during the period were 
Black Africans (Mqoqi et al., 2004). The Eastern Cape Province Cancer Registry reported 
cervical cancer ASRs of 21.7 per 100 000 for the period 1998-2002 and 19.4 per 100 000 for 
2003-2007 (Somdyala et al., 2010; Somdyala et al., 2013).  In this study cervical cancer 
incidence accounted for 36.6% of all female cancers with an ASR of 23.0 per 100 000 for 
BFC population. The trend of cervical cancer incidence over the 19-year period was observed 
to have decreased with White females 43% less likely to have cervical cancer compared to 
Black African females. The natural history of cervical cancer has been studied and it has been 
concluded that the persistant infection of the cervix by the oncogenic types of Human 
Papilloma Virus (HPV 16 & HPV 18) is the necessary cause in 72% of cervical cancers in 
Africa (Sitas et al., 2008; Denny, 2010).  
 
Breast cancer, on the other hand, is reported to be higher in the White female population 
compared to the Black African female population, with high incidence rates noted in South 
Africa, 35 per 100 000 (Verobiof, Sitas & Verobiof, 2001; Mqoqi et al., 2004; Parkin et al., 
2008). Mqoqi et al., 2004 reported breast cancer as the leading cancer (20.0%) of all cancers 
reported in White South African females during 1998 and 1999 with an average ASR of 76 
per 100 000. The Eastern Cape Province Cancer Registry reported a breast cancer incidence 
rate of 7.5 per 100 000 population for the period 1998-2002 and for 2003-2007 (Somdyala et 
al., 2010; Somdyala et al., 2013). In this study breast cancer accounted for 22.0% of all 
female cancers and had an ASR of 20.0 per 100 000 for the BFC population. White females 
were also observed to be almost three times more likely to have breast cancer compared to 
Black African females. Even though breast cancer trends over the 19-year period were 
observed to be stable, the interaction between race and year (Figure 23) showed that Black 
African female cases actually increased whilst White females decreased. In an African 
setting, the family history has been reported to be the indicator of breast cancer risk. Other 
risk factors for breast cancer are reported to be related to menstrual and reproductive factors, 
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high body mass index, high alcohol  consumption, physical inactivity and exposure to 
exogenous hormones either as   contraceptives or as postmenapausal hormon replacement 
therapy (Sitas et al., 2008).            
 
Figure 25. Comparison of the top-10 cancer sites by sex, Frere hospital 1991-2009 and 
Eastern Cape Province Cancer Registry, 2003-2007  
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Limitations 
The use of hospital clinical administrative data system has limitations. A primary limitation 
of this study is its reliance on routine health records collected not primarily for research 
purpose. Routine data capture may not meet the rigorous standards of a focused study. An 
undeterminable level of inaccuracy may also be associated with these records. However, they 
are the only available data on cancer cases presented at Frere Hospital and are used routinely 
for clinical management and administrative purposes. This study had an under-counting of 
cancer cases in BFC urban area as patients attending the private sector were not included. 
However, such patients were thought to make a small section of the population as according 
to the General Household Survey (GHS) only 18.2% of households in the Eastern Cape 
Province prefer private sector health facilities (Statistics South Africa, 2013). 
 
It could also be assumed that since this is a tertiary hospital, bias towards cases with higher 
survival opportunities existed. In addition, tertiary hospitals are known to have an increase in 
number of cancers in which certain specialist within the hospital have an interest in (Parkin et 
al., 2008). Despite these limitations, this initial analysis of cancer cases that occurred over a 
19-year period provides useful descriptive background information on recorded cancer cases 
presenting at Frere Hospital. 
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CHAPTER VI 
 
Conclusions and Recommendations 
 
Despite the limitations of this study it is clear that efforts are in place to keep up-to-date 
cancer patient information at Frere Hospital Oncology and Radiation Department, as 89% of 
the records retrieved had all the variables for analysis. Retrieved data were useful in 
describing the increasing burden of cancer at Frere Hospital, as shown by the increase in 
number of cancer cases from 1991 to 2009. The estimated cancer incidence rates in this study 
showed that major cancers at BFC urban area were lung and prostate cancers in males, cervix 
and breast in females. These incidence rates were in agreement with the rates reported by the 
rural population-based EC Province Cancer Registry with the exception of oesophagus cancer 
incidence rates which were low. Oesophagus cancer was reported in 1957 as the leading 
cancer in both males and females in this urban hospital and is still reported as the leading 
cancer by the EC Province Cancer Registry. Therefore, oesophagus cancer cases that might 
not have been referred for radiotherapy at Frere Hospital should be investigated in order to 
produce undoubted incidence rate estimates of this cancer in this urban area. 
 
 
 
Differences in trends of the leading cancers at BFC urban area existed over the 19 year 
period. Prostate cancer incidence rates decreased considerably from year 1999 whereas lung 
cancer incidence rates decreased between 2000 and 2003. Cervix and breast cancer„s 
incidence rates remained stable over the period.  It is therefore recommended that cancer 
incidence rates for leading cancers in this urban area must be monitored in order to detect 
changes in the existing trends. This can be done by establishing a population-based cancer 
register in BFC to monitor cancer incidence in this urban area. Information generated by such 
a cancer register will inform future research making it possible to examine urban-rural 
variations in cancer profiles thus giving a more comprehensive picture of the cancer burden 
in the Eastern Cape Province.  
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APPENDIX A  
 
EASTEN CAPE PROVINCE CANCER REGISTRY CONFIDENTIAL CANCER NOTIFICATION FORM 
 
Registry No. 
Today’s Date 
 
Day   Month  Year 
  
 
 
Please complete and return to;     
Medical Research Council 
Burden of Disease Research Unit 
PO Box 19070 
Tygerberg 
7505 
 
PATIENT INFORMATION 
 
 
Surname………………………………… … ………………..     First 
Name…………………………………………………………………………….. 
 
Other Name……………………………………………………….         Maiden Name (Married 
female)……………………………………….. 
 
 
 
                                                                                                                                              Day  Month             Year 
 
Sex M    F   Estimated Age      Date of Birth  
 
 
 
Identity Number 
 
 
PATIENT ADDRESS/ RESIDENCE/CONTACT 
 
 
Magisterial 
Area/Town………………………………………………………………………………………………………………………………………. 
 
Address Details 
……………………………………………………………………………………………………………………………………………………
…………… 
 
……………………………………………………………………………………………………………………………………………………
……… 
 
Phone (Work)….........Code          No........................................................          Cell….................................... 
 
Chief /Headman/ Mayor/ 
Councillor…………………………………………………………………………………………………………………….. 
 
 
Ethnic Group     Black          White   Asian  Coloured  Unknown 
 
 
Marital Status  Single (Never married)          Married            Widowed           Divorced          Separated            Minor 
 
Unknown 
  
  
Smoker  Stopped  Years                                             Non-smoker 
 
 
 
SOURCE OF INFORMATION 
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Hospital/ Private Practi tioner/ Clinic/ 
Laboratory/Other…………………………………………………………………………………….............. 
 
Ward……………………………………………………………………………………………………………………………………………
……………..... 
 
 
Folder /In-Patient/Out-Patient Number    
 
 
 
TUMOUR INFORMATION 
 
Full 
Diagnosis…………………………………………………………………………………………………………………………………………
…....... 
 
Site of 
Tumour…………………………………………………………………………………………………………………………………………
……... 
 
Pathology Report/ Radiology/Scope/.Disease History/Notes 
 
……………………………………………………………………………………………………………………………………………………
…………… 
 
……………………………………………………………………………………………………………………………………………………
…………… 
 
Ever had Pap-smear? Yes No                Ever had PSA testing? Yes         No  
 
 
Year? ………………Parity………………..        Year………………………. 
 
 
 
Pathology Number 
 
 
Topography C /    /  
 
 
Morphology  M   / 
 
 
Behaviour 
 
 
Extent of Disease   1      2      3      4      Unknown 
 
 
 
Stage of Disease             I             II               III                IV          Unknown 
 
 
HIV Status:            Negative    Positive             Unknown 
 
 
Incidence Date  
 
 
Basis of Diagnosis:  Clinical only          Radiography             Pathology             Death Certificate Only  
 
 
             Scan           Unknown             Other Specify 
 
 
……………………………………………………………………………………………………………………………………………………
……………. 
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TREATMENT 
 
Surgery              Radiotherapy             Chemotherapy             Hormone Therapy                   Immunotherapy               
Palliative 
 
 
             Unknown            Other (Specify)     
 
……………………………………………………………………………………………………………………………………………………
…………….. 
 
VITAL STATUS 
 
Date of last follow-up          Alive  Dead 
 
 
Abstraction done 
by:……………………………………………………………………………………………………………………………………… 
Please print name 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
49 
 
APPENDIX B 
OFFICE OF THE DEAN 
DEPARTMENT OF RESEARCH DEVELOPMENT 
 
 
 
 
 
 
 
 
 
12 April 2013 
 
 
 
To Whom It May Concern 
 
 
I hereby certify that the Senate Research Committee of the University of the Western 
Cape has approved the methodology and ethics of the following research project by: 
Ms N Sithole (School of Public Health) 
 
 
 
Research Project: Cancer profile in an urban hospital of the Eastern Cape 
      
 
 
Registration no:  13/2/26 
 
 
 
Any amendments, extension or other modifications to the protocol must be 
submitted to the Ethics Committee for approval. 
 
 
The Committee must be informed of any serious adverse event and/or 
termination of the study. 
 
 
 
 
 
Ms Patricia Josias 
Research Ethics Committee Officer 
University of the Western Cape 
 
  
 
 
 
Priv ate Bag X 17, Bel lvil le 753 5, South Afri ca  
T: +27 21 959 2988 /2948 . F : +27 21 959 317 
E: pjosias@uwc.ac.za 
www.uwc.ac.za 
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APPENDIX C 
" 
 
 
 
Eastern Cape Department of Health 
 
Enquiries: Zonwabele Merile  Tel No: 040 608 0830 
 
Date: 061 May 2013 
e-mail address: zonwabele.merile@impilo.ecprov.gov.za 
Fax No: 043 6421409 
 
Dear Ms Nomfuneko Sithole 
 
 
 
Re: Cancer profile in an urban hospital of the Eastern Cape Province: a 19 year case series study 
 
 
The  Department  of  Health  would  like  to  inform  you that  your   application  for  conducting  a research  on  the 
abovementioned topic has been approved based on the following conditions: 
1. During your study, you will follow the submitted protocol with ethical approval and can only deviate from it after 
 
having a written approval from the Department of Health in writing. 
 
2. You are advised to ensure, observe and respect the rights and culture of your research participants and maintain 
confidentiality of their identities and shall remove or not collect any information which can be used to link the 
participants. 
3.  The Department of Health  expects you  to provide  a progress  on your study every 3 months (from date you 
 
received this letter) in writ'lng. 
 
4. At the end of your study, you will be expected to send a full written report with your findings and implementable 
recommendations to the  Epidemiological Research  & Surveillance  Management.  You may be invited to the 
department to come and present your research findings with your implementable recommendations. 
5. Your results on the Eastern Cape  will not  be presented anywhere  unless  you have  shared them with the 
 
Department of Health as indicated above. 
 
 
 
Your compliance in this regard will be highly appreciated. 
 
 
 
 
 
D CTOR: EPIDEMIOLOGICAL RESEARCH & SURVEILLANCE MANAGEMENT 
 
 
 
 
 
 
!kmnvo ciu;umnnl!iie>' ·· 
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APPENDIX D  
 
Overall malignant cases by site, age group and sex, 1991-2009 
Cancer Site 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ Total % ICD 10 
a.Males             
Lip 0 0 1 2 7 10 7 8 5 40 0.5 C00 
Tongue 0 0 1 12 47 125 120 69 21 395 5.2 C01-C02 
Mouth 0 2 4 13 90 157 175 120 37 598 7.8 C03-C06 
Salivary glands 0 0 0 3 8 7 9 9 3 39 0.5 C07-C08 
Tonsil 0 0 0 5 45 64 58 30 9 211 2.8 C09 
Pharynx 0 4 3 15 25 69 73 25 9 223 2.9 C10-C14 
Oesophagus 0 1 2 7 58 77 58 39 9 251 3.3 C15 
Stomach 0 0 0 3 11 14 17 4 0 49 0.6 C16 
Small intestine 0 0 1 1 3 0 1 0 1 7 0.1 C17 
Colon 0 4 9 32 44 49 50 45 3 236 3.1 C18 
Rectum 0 1 7 14 24 36 49 31 9 171 2.2 C19-C20 
Anus 0 0 3 10 13 14 11 5 6 62 0.8 C21 
Liver 0 1 5 5 2 3 2 4 0 22 0.3 C22 
Gallbladder 0 0 0 1 0 2 1 0 0 4 0.1 C23 
Pancreas 0 0 1 0 3 7 9 2 0 22 0.3 C25 
Nasal cavity & Middle 0 0 0 1 1 1 1 2 1 7 0.1 C30 
Accessory sinus 0 2 6 9 24 32 34 19 7 133 1.7 C31 
Larynx 0 0 4 3 70 200 212 116 29 634 8.3 C32 
Trachea, Bronchus, 
Lung 
0 2 4 65 210 456 428 222 34 1,421 18.6 C33-C34 
Bone 7 44 24 9 4 4 2 3 2 99 1.3 C40-C41 
Melanoma skin 0 0 5 7 16 25 27 14 5 99 1.3 C43 
Other skin 0 1 4 13 29 43 52 47 25 214 2.8 C44 
Mesothelioma 0 0 0 0 5 5 9 7 1 27 0.4 C45 
Kaposi sarcoma 0 4 31 61 40 10 9 4 3 162 2.1 C46 
Connective & Soft 
tissue 
3 24 23 10 17 22 26 13 5 143 1.9 C47-C49 
Breast 0 0 0 3 9 21 27 23 9 92 1.2 C50 
Penis 0 0 1 5 5 11 5 2 3 32 0.4 C60 
Prostate 0 0 0 1 9 65 245 171 55 546 7.1 C61 
Testis 12 2 14 22 19 13 8 3 2 95 1.2 C62 
Kidney 36 4 0 0 13 9 16 6 0 84 1.1 C64 
Bladder 0 2 2 2 8 19 31 39 14 117 1.5 C67 
Eye 30 1 2 10 10 7 9 6 4 79 1.0 C69 
Brain 31 18 8 20 15 29 17 5 0 143 1.9 C70-C72 
Thyroid 0 0 0 1 2 13 7 4 1 28 0.4 C73 
Other endocrine 
gland 
0 1 3 3 6 4 3 2 0 22 0.3 C75 
ILL-Defined 1 2 6 11 31 40 33 22 6 152 2.0 C76 
Lymph nodes 1 1 1 7 24 52 64 33 11 194 2.5 C77 
Unknown primary 1 2 8 12 43 54 62 35 7 224 2.9 C80 
Hodgkin's disease 11 21 32 23 13 16 10 14 1 141 1.8 C81 
Non-Hodgkin's 
Lymphoma 
10 12 10 40 29 38 33 21 7 200 2.6 C82-
C85;C96 
Multiple myeloma 0 0 0 4 27 53 54 35 9 182 2.4 C90 
Lymphoid leukemia 11 8 1 1 0 4 8 5 0 38 0.5 C91 
Myeloid leukemia 1 3 2 1 1 6 3 1 0 18 0.2 C92-C94 
Total 155 167 228 467 1,060 1,886 2,075 1,265 353 7,656 100.0  
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Cancer Site 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ Total % ICD 10 
b. Females             
Lip 0 0 3 0 4 9 10 8 3 37 0.3 C00 
Tongue 0 0 2 2 3 16 35 24 9 91 0.8 C01-C02 
Mouth 0 3 5 8 17 46 86 57 34 256 2.1 C03-C06 
Salivary glands 0 5 7 8 8 10 16 8 5 67 0.6 C07-C08 
Tonsil 0 0 1 1 3 10 8 9 5 37 0.3 C09 
Pharynx 0 1 3 6 12 14 19 9 8 72 0.6 C10-C14 
Oesophagus 0 0 0 13 32 53 55 25 9 187 1.5 C15 
Stomach 0 1 2 2 5 5 14 9 3 41 0.3 C16 
Small intestine 0 0 1 1 2 1 2 1 0 8 0.1 C17 
Colon 0 3 13 25 44 38 60 26 9 218 1.8 C18 
Rectum 0 0 8 14 25 30 32 24 13 146 1.2 C19-C20 
Anus 0 0 2 7 4 9 11 4 6 43 0.4 C21 
Liver 0 0 1 1 0 1 3 2 0 8 0.1 C22 
Gallbladder 0 0 0 0 1 7 4 2 0 14 0.1 C23 
Pancreas 0 1 0 2 4 5 5 1 0 18 0.1 C25 
Nasal cavity & Middle 0 0 1 0 3 4 3 2 1 14 0.1 C30 
Accessory sinus 0 0 5 8 11 15 21 16 3 79 0.7 C31 
Larynx 0 0 0 5 13 29 32 12 2 93 0.8 C32 
Trachea, Bronchus, Lung 0 0 3 8 71 114 141 73 15 425 3.5 C33-C34 
Bone 2 45 18 4 9 6 3 1 1 89 0.7 C40-C41 
Melanoma skin 0 0 7 8 16 17 36 34 21 139 1.2 C43 
Other skin 0 0 2 16 14 32 31 35 30 160 1.3 C44 
Mesothelioma 0 0 0 0 1 0 2 1 1 5 0.0 C45 
Kaposi sarcoma 0 3 56 69 28 15 4 1 2 178 1.5 C46 
Connective & Soft tissue 5 21 22 21 25 13 23 12 4 146 1.2 C47-C49 
Breast 0 4 65 346 648 605 509 346 139 2,662 22.0 C50 
Vulva Vagina 0 3 8 10 29 28 46 25 9 158 1.3 C51-C52 
Cervix 0 1 64 465 940 1,064 1,156 569 168 4,427 36.6 C53 
Corpus uteri 0 0 1 4 15 49 150 92 15 326 2.7 C54 
Ovary 1 16 26 42 58 63 73 45 11 335 2.8 C56 
Placenta 0 6 35 33 19 9 7 2 1 112 0.9 C58 
Kidney 30 2 3 6 5 7 6 4 1 64 0.5 C64 
Bladder 0 0 0 3 0 11 13 18 11 56 0.5 C67 
Eye 24 1 20 26 19 11 7 10 5 123 1.0 C69 
Brain 25 25 7 18 19 18 14 6 0 132 1.1 C70-C72 
Thyroid 0 2 12 27 28 20 26 12 6 133 1.1 C73 
Other endocrine gland 0 1 4 5 7 8 4 2 0 31 0.3 C75 
ILL-Defined 2 1 4 9 28 31 37 20 11 143 1.2 C76 
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Lymph nodes 0 0 4 7 11 19 29 13 9 92 0.8 C77 
Unknown primary 0 2 3 16 21 31 40 31 6 150 1.2 C80 
Hodgkin's disease 6 13 18 21 15 9 12 9 2 105 0.9 C81 
Non-Hodgkin's 
Lymphoma 
6 11 22 45 31 30 50 32 7 234 1.9 C82-
C85;C96 
Multiple myeloma 0 0 0 10 18 45 60 30 14 177 1.5 C90 
Lymphoid leukemia 8 14 1 2 1 1 7 2 4 40 0.3 C91 
Myeloid leukemia 0 1 2 2 1 1 2 0 1 10 0.1 C92-C94 
Total 109 186 461 1,326 2,268 2,559 2,904 1,664 604 12,081 100.0  
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APPENDIX E  
 
Estimated BFC minimal cancer incidence rates by cancer site, age group and sex, 1991-2009 
Cancer site 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ Total % CR ASR ICD 10 
a. Males               
Lip 0.0 0.0 0.0 0.1 0.7 0.7 0.8 4.9 2.6 9.9 0.6 0.3 0.4 C00 
Tongue 0.0 0.0 0.0 1.0 1.9 7.4 16.7 18.7 18.5 64.2 3.8 2.0 2.9 C01-C02 
Mouth 0.0 0.0 0.0 0.6 3.7 11.3 20.5 19.5 18.5 74.2 4.4 2.6 3.7 C03-C06 
Salivary glands 0.0 0.0 0.0 0.0 0.6 0.7 2.1 5.7 0.0 9.1 0.5 0.3 0.5 C07-C08 
Tonsil 0.0 0.0 0.0 0.3 1.6 3.9 5.9 7.3 10.6 29.6 1.8 0.9 1.3 C09 
Pharynx 0.0 0.2 0.0 0.9 1.3 4.9 10.9 5.7 5.3 29.1 1.7 1.2 1.7 C10-C14 
Oesophagus 0.0 0.0 0.2 0.4 4.9 7.4 11.7 15.5 2.6 42.7 2.5 1.9 2.6 C15 
Stomach 0.0 0.0 0.0 0.2 1.0 2.1 3.8 0.8 0.0 7.9 0.5 0.4 0.6 C16 
Small intestine 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.6 3.1 0.2 0.0 0.1 C17 
Colon 0.0 0.1 0.4 1.7 3.0 6.0 14.2 21.2 5.3 51.9 3.1 2.1 2.9 C18 
Rectum 0.0 0.1 0.1 0.6 1.6 4.6 12.1 19.5 10.6 49.3 2.9 1.5 2.3 C19-C20 
Anus 0.0 0.0 0.1 0.4 0.4 0.9 1.7 0.8 5.3 9.6 0.6 0.3 0.4 C21 
Liver 0.0 0.1 0.3 0.2 0.1 0.5 0.0 0.0 0.0 1.2 0.1 0.1 0.1 C22 
Pancreas 0.0 0.0 0.0 0.0 0.0 1.2 1.7 0.8 0.0 3.6 0.2 0.2 0.2 C25 
Nasal cavity & 
Middle 
0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 1.0 0.1 0.0 0.0 C30 
Accessory sinus 0.0 0.1 0.2 0.2 1.2 1.4 2.5 4.1 5.3 14.9 0.9 0.5 0.7 C31 
Larynx 0.0 0.0 0.2 0.1 3.7 16.9 26.4 32.6 18.5 98.3 5.8 3.4 5.0 C32 
Trachea, 
Bronchus, Lung 
0.0 0.2 0.3 4.3 20.0 68.4 111.4 116.4 58.1 378.9 22.5 14.5 21.0 C33-C34 
Bone 0.2 1.1 0.4 0.5 0.0 0.7 0.8 0.0 5.3 9.1 0.5 0.5 0.5 C40-C41 
Melanoma skin 0.0 0.0 0.3 0.2 1.6 3.5 5.4 6.5 5.3 22.9 1.4 0.9 1.2 C43 
Other skin 0.0 0.1 0.2 0.6 1.9 4.4 12.6 26.9 47.5 94.1 5.6 2.0 2.9 C44 
Mesothelioma 0.0 0.0 0.0 0.0 0.3 0.7 2.9 4.9 2.6 11.4 0.7 0.3 0.5 C45 
Kaposi sarcoma 0.0 0.1 1.3 3.7 2.5 0.9 0.8 1.6 2.6 13.6 0.8 1.2 1.2 C46 
Connective & 
Soft tissue 
0.2 0.3 0.7 0.3 1.8 1.2 4.6 4.1 2.6 15.7 0.9 0.8 1.0 C47-C49 
Breast 0.0 0.0 0.0 0.1 0.6 1.4 4.6 4.1 10.6 21.3 1.3 0.5 0.8 C50 
Penis 0.0 0.0 0.0 0.3 0.1 1.8 0.4 0.8 2.6 6.2 0.4 0.2 0.3 C60 
Prostate 0.0 0.0 0.0 0.1 1.2 9.2 67.4 88.7 81.8 248.5 14.7 5.6 9.2 C61 
Testis 0.1 0.1 0.8 1.9 2.4 1.6 2.1 1.6 2.6 13.3 0.8 1.0 1.0 C62 
Kidney 0.7 0.1 0.0 0.0 1.0 1.8 3.8 0.8 0.0 8.3 0.5 0.6 0.7 C64 
Bladder 0.0 0.1 0.1 0.0 0.9 3.7 9.2 21.2 31.7 66.8 4.0 1.3 2.1 C67 
Eye 0.6 0.1 0.1 0.2 0.6 0.2 1.3 0.8 5.3 9.2 0.5 0.4 0.4 C69 
Brain 0.9 0.7 0.3 1.1 1.2 5.8 6.3 2.4 0.0 18.7 1.1 1.4 1.7 C70-C71 
Thyroid 0.0 0.0 0.0 0.0 0.3 0.9 0.8 1.6 0.0 3.7 0.2 0.2 0.2 C73 
Other 
endocrine gland 
0.0 0.0 0.2 0.1 0.7 0.5 0.8 0.8 0.0 3.1 0.2 0.2 0.3 C75 
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Ill-Defined 0.0 0.1 0.2 0.7 2.7 4.6 8.0 11.4 2.6 30.3 1.8 1.3 1.8 C76 
Lymph nodes 0.0 0.0 0.1 0.5 1.0 5.3 9.2 9.0 15.8 41.0 2.4 1.2 1.8 C77 
Unknown 
primary 
0.0 0.1 0.3 1.0 4.0 6.5 15.1 15.5 13.2 55.6 3.3 2.1 2.9 C80 
Hodgkin's 
disease 
0.2 0.9 1.4 1.2 0.7 1.4 2.1 6.5 2.6 17.1 1.0 1.1 1.2 C81 
Non-Hodgkin's 
Lymphoma 
0.5 0.3 0.6 2.8 1.5 4.9 7.5 12.2 10.6 40.9 2.4 1.8 2.2 C82-
C85;C96 
Multiple 
myeloma 
0.0 0.0 0.0 0.2 1.9 6.0 10.5 17.9 13.2 49.7 2.9 1.5 2.2 C90 
Lymphoid 
leukemia 
0.2 0.3 0.1 0.1 0.0 0.5 1.7 3.3 0.0 6.0 0.4 0.3 0.4 C91 
Myeloid 
leukemia 
0.0 0.1 0.1 0.1 0.1 0.9 0.0 0.8 0.0 2.2 0.1 0.1 0.2 C92-C94 
Total 3.7 4.9 8.7 26.9 75.5 206.7 420.8 517.8 422.3 1687.2 100.0 58.9 83.2  
Cancer site 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ Total % CR ASR ICD 10 
b. Females               
Lip 0.0 0.0 0.1 0.0 0.0 0.6 0.6 2.0 2.5 5.7 0.7 0.2 0.2 C00 
Tongue 0.0 0.0 0.0 0.2 0.1 1.3 2.5 6.6 6.2 17.0 1.7 0.5 0.6 C01-C02 
Mouth 0.0 0.1 0.2 0.3 0.5 3.6 9.3 11.1 22.5 47.5 6.2 1.5 1.7 C03-C06 
Salivary glands 0.0 0.0 0.3 0.3 0.4 0.4 2.3 0.5 2.5 6.6 0.7 0.3 0.4 C07-C08 
Tonsil 0.0 0.0 0.0 0.0 0.4 1.3 1.4 1.5 2.5 7.1 0.7 0.3 0.3 C09 
Pharynx 0.0 0.0 0.2 0.3 0.8 1.3 2.3 2.0 2.5 9.3 0.7 0.5 0.5 C10-C14 
Oesophagus 0.0 0.0 0.0 1.0 2.2 5.1 7.9 6.1 5.0 27.3 1.4 1.4 1.6 C15 
Stomach 0.0 0.1 0.1 0.1 0.5 0.4 3.1 1.5 3.7 9.5 1.0 0.4 0.4 C16 
Small intestine 0.0 0.0 0.0 0.1 0.3 0.2 0.3 0.0 0.0 0.8 0.0 0.1 0.1 C17 
Colon 0.0 0.1 0.3 1.3 3.2 5.1 11.9 12.1 8.7 42.7 2.4 2.1 2.3 C18 
Rectum 0.0 0.0 0.2 0.7 1.7 4.0 4.5 8.1 10.0 29.2 2.7 1.2 1.3 C19-C20 
Anus 0.0 0.0 0.2 0.3 0.3 0.6 2.0 1.0 2.5 6.7 0.7 0.3 0.3 C21 
Liver 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 0.0 0.0 0.0 C22 
Gallbladder 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.5 0.0 1.7 0.0 0.1 0.1 C23 
Pancreas 0.0 0.0 0.0 0.1 0.1 0.6 0.8 0.5 0.0 2.1 0.0 0.1 0.2 C25 
Nasal cavity & 
Middle 
0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.5 0.0 1.2 0.0 0.1 0.1 C30 
Accessory sinus 0.0 0.0 0.1 0.2 0.3 1.1 1.7 2.0 1.2 6.6 0.3 0.3 0.4 C31 
Larynx 0.0 0.0 0.0 0.1 0.4 2.1 5.1 4.5 2.5 14.7 0.7 0.6 0.8 C32 
Trachea, 
Bronchus, Lung 
0.0 0.0 0.1 0.4 5.9 13.4 26.6 24.2 12.5 83.0 3.4 3.9 4.7 C33-C34 
Bone 0.0 0.8 0.5 0.2 0.4 0.2 0.0 0.0 0.0 2.1 0.0 0.3 0.3 C40-C41 
Melanoma skin 0.0 0.0 0.4 0.4 0.8 1.7 5.1 9.1 13.7 31.1 3.8 1.0 1.1 C43 
Other skin 0.0 0.0 0.1 0.6 0.8 2.5 5.1 10.1 29.9 49.0 8.2 1.3 1.3 C44 
Mesothelioma 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.5 1.2 2.4 0.3 0.1 0.1 C45 
Kaposi sarcoma 0.0 0.1 2.0 3.0 1.4 0.9 0.8 0.5 0.0 8.8 0.0 1.2 1.0 C46 
Connective & 
Soft tissue 
0.2 0.4 0.4 0.8 1.7 1.1 1.7 2.5 1.2 10.2 0.3 0.8 0.8 C47-C49 
Breast 0.0 0.0 2.3 15.6 39.7 54.4 69.5 84.7 86.1 352.4 23.6 18.4 20.2 C50 
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Vulva Vagina 0.0 0.1 0.2 0.3 1.7 1.9 5.4 3.5 3.7 16.8 1.0 0.8 1.0 C51-C52 
Cervix 0.0 0.0 2.2 16.2 42.1 64.8 90.1 91.8 76.1 383.4 20.9 20.7 23.0 C53 
Corpus uteri 0.0 0.0 0.0 0.1 0.8 4.7 18.9 25.7 12.5 62.7 3.4 2.3 2.8 C54 
Ovary 0.1 0.4 1.1 2.4 4.2 7.4 11.3 11.6 7.5 46.0 2.1 2.7 3.0 C56 
Placenta 0.0 0.1 1.7 1.2 1.0 0.9 1.4 0.5 0.0 6.9 0.0 0.8 0.8 C58 
Kidney 0.6 0.0 0.2 0.3 0.4 1.1 0.6 1.5 1.2 5.8 0.3 0.4 0.4 C64 
Bladder 0.0 0.0 0.0 0.1 0.0 0.8 2.3 5.5 6.2 14.9 1.7 0.4 0.5 C67 
Eye 0.4 0.0 0.2 0.5 0.6 0.6 0.6 1.5 0.0 4.4 0.0 0.4 0.4 C69 
Brain 0.9 0.7 0.3 1.1 1.2 2.6 3.1 2.5 0.0 12.5 0.0 1.1 1.2 C70-C71 
Thyroid 0.0 0.1 0.5 1.1 1.7 0.9 3.1 3.5 5.0 16.0 1.4 0.9 0.9 C73 
Other 
endocrine gland 
0.0 0.0 0.2 0.5 0.3 0.8 0.8 1.0 0.0 3.6 0.0 0.3 0.3 C75 
Ill-Defined 0.1 0.0 0.0 0.5 2.6 3.0 6.2 5.5 7.5 25.4 2.1 1.2 1.3 C76 
Lymph nodes 0.0 0.0 0.2 0.3 0.9 2.5 3.7 3.0 5.0 15.5 1.4 0.7 0.8 C77 
Unknown 
primary 
0.0 0.1 0.1 0.6 1.8 4.0 7.6 11.1 5.0 30.2 1.4 1.4 1.6 C80 
Hodgkin's 
disease 
0.2 0.4 0.7 1.1 0.8 0.6 1.7 3.5 1.2 10.1 0.3 0.7 0.7 C81 
Non-Hodgkin's 
Lymphoma 
0.2 0.2 0.9 2.2 1.8 3.2 9.6 9.6 6.2 33.9 1.7 1.9 2.0 C82-
C85;C96 
Multiple 
myeloma 
0.0 0.0 0.0 0.6 1.3 5.7 9.3 6.1 7.5 30.4 2.1 1.4 1.6 C90 
Lymphoid 
leukemia 
0.1 0.2 0.1 0.1 0.1 0.0 1.1 0.5 2.5 4.7 0.7 0.2 0.2 C91 
Myeloid 
leukemia 
0.0 0.1 0.1 0.0 0.1 0.2 0.6 0.0 0.0 1.0 0.0 0.1 0.1 C92-C94 
Total 2.6 3.9 16.1 54.7 125.4 208.9 342.6 381.4 364.3 1499.9 100.0 75.3 83.3  
 
 
 
 
